新一批京津冀医耗集采结果公布！医疗费有望进一步降低

Group 1 - The core viewpoint of the news is the announcement of the selection results for the latest round of medical consumables bulk procurement in the Beijing-Tianjin-Hebei "3+N" alliance, which aims to reduce prices and alleviate the financial burden on patients [1][2]. - The bulk procurement includes medical films and hemostatic materials, with a total of 95 companies selected for medical films, including well-known domestic and international firms such as Agfa, Fujifilm, Konica Minolta, and Ricoh, covering 2,466 product specifications [1]. - The procurement process utilizes a combination of volume-based pricing, negotiation, and dual selection to optimize costs, which is expected to lead to a return of prices for these consumables to a more reasonable range [1]. Group 2 - The medical film market in China has an annual usage of approximately 650 million sheets, with a market size close to 6 billion yuan, making it a significant component of operational costs for medical institutions [1]. - The hemostatic materials procurement includes over 10 types of products such as hemostatic gauze and collagen sponge, with 126 product specifications selected from major manufacturers like Medtronic and Johnson & Johnson [1]. - The "3+N" alliance, led by Beijing, Tianjin, and Hebei, has previously conducted multiple rounds of bulk procurement for various medical consumables, achieving positive results in price reduction, supply assurance, and market regulation [2].